Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SB-204269 in phase I for epilepsy

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Scios to copromote venlafaxine with Wyeth-Ayerst

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

Sertindole clinical trial results reported at APA meeting

May 17, 1996

NIH scientists report ligands for alpha5-containing GABA-A receptors

May 17, 1996

Paroxetine approved for new indication

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...